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Conclusions: It can be concluded that
all cancer cells tested have higher telo-
merase expression and activity, as com-
pared to normal cells. The high expression
and activity of telomerase in cancer cells
can be explained by amplified TERT gene.
Therefore telomerase can be a good
cancer marker provided quantitative
analysis is carried out. Grant support: The
work was sponsored by KSN grants No
4P05B 072 17 and 6P05E 102 20.
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Background: The erbS family of proto-
oncogenes (erbS-1, erbS-2, erbS-3, erbS-
4) and their receptors play an important
role in normal cell growth and neoplastic
transformation. Literature data indicate
that some abnormalities of erbS oncogene
play an important role in breast cancer
development, correlate with tumor aggre-
ssiveness and with worse clinical outcome.
Therefore, these abnormalities may poten-
tially have prognostic and therapeutic
relevance. Aim of the stUdy: To determine
the number of gene copies within erbS
oncogene family in breast cancer. The
relationship of abnormalities /CAln in the
dinucleotides and the loss of hetero-
zygosity (LOH) in erbS-1 were analyzed in
. relation to clinical and pathological fea-
tures of the tumors and to chemotherapy
response.
Matherials and methods: StUdy
subjects included 50 chemotherapy naive
LABC (any T, N2, any N, T4) patients
(pts). All pts received induction chemothe-
rapy. Tumor measurement was performed
after each cycle and at the completion
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of induction chemotherapy. Double diffe-
rential PCR (ddPCR) was used for de-
tection of erbS oncogene family abnor-
malities (gene amplification/deletion).
Microsatellite polymorphism of erbS-1 was
examined by PCR with fluorescently
labeled primers, followed by capillary
electrophoresis and quantitative analysis
of PCR product with GeneScanTM sys-
tem, using automated ASI PRSM 310.
Results: Amplifications of erbB-1, erbB-
2, erbB-3, erbB-4 (defined as AGCN value
of > 1.6) were detected in 5.9%, 26.5%,
2.9% and 2.9% of examined cases,
respectively. Deletions, defined as AGCN
value of < 0.4, accompanied only erbS-1
amplification and occurred in 26.5% of all
cases. There was a polymorphic simple
sequence repeat region of 12-20 CA
detected in the first intron of erbS-1.
Homozygotes comprised 31 % of the exa-
mined group. The majority of homozygous
pts revealed 14/14 CA repeat combination.
LOH (most frequently affecting shorter
allele) was determined in breast cancer
heterozygotes and occurred in 50%
of cases. Correlations between these fin-
dings and clinical outcomes will be pre-
sented.
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Objectives: The purpose of the study
was to evaluate the frequency of abnormal
DNA content in squamous cancer cells
(SCLC) and analyze its correlation with
late survival rates after surgical treatment.
Many previous studies included attempts
to associate DNA quantification with
prognosis for lung cancer. However, there
is still considerable divergence of opinion
about its prognostic value.
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Methods: A group of 110 patients
surgically treated because of SCC was
analyzed. Paraffin-embedded pathologic
material underwent cytometric analysis.
Post-operative follow-up was performed
with standard follow-up visits. The 2 tests
toxstatistical analysis was carried out
using Mann-Whitney's and compare the
following parameters in both groups:
clinical staging, grading, tumor size,
distant and local metastasis, tumor lo-
cation, type of surgical procedure, local
recurrence and survival time. The survival
curves were drawn using the Kaplan-Meier
method and two and five years survival
rate were assessed. Clinical staging,
regional metastasis and ploidy, having a
great impact on survival rates, were
analyzed with multivariational analysis.
Results: 50 (45%) tumors were DNA
aneuploid. There were no significance
between the ploidy groups in clinical
staging, grading, tumor size and location
and type of surgical procedure. The two
years survival rate in patients with ane-
uploid cancers (16,7%) was significantly
worse than in those with diploid tumors
(50%)(p<O,05). This significance wasn't
observed five years after surgery between
aneuploid (13,5%) and diploid cancers
(20,5%).
Conclusions: DNA content abnor-
malities were found to be an important
prognostic factor in patients with SCLC in
two years follow up. However the DNA
ploidy might not be a predictive factor on
long term (5 years) survival rate in this
group of patients.
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Szlak sygnafowy nabfonkowego
czynnika wzrostu (ang. epidermal growth
factor, EGF) i jego receptory
(najwazniejsze z nich to erbB-1 i erbS-2)
odgrywajq waznq rol~ w patogenezie i pro-
gresji raka pfuca. Kliniczne znaczenie
nadekspresji tych receptorow pozostaje
nadal przedmiotem kontrowersji a dotych-
czasowe badania przynosHy sprzeczne
wyniki. Z uwagi na opracowane ostatnio
leki 0 wybiorczym dziafaniu przeciwno-
wotworowym, dziafajqce poprzez powyz-
sze receptory, poznanie rokowniczego
znaczenia tych zaburzen moze odegra6
waznq rol~ w ustalaniu optymalnego
sposobu leczenia. Celem pracy byfaocena
rokowniczego znaczenia anomalii sredniej
liczby kopii genow (ang. avarage gene
copy numer, AGCN) u chorych na niedro-
bnokomorkowego raka pfuca poddanych
resekcji miqzszu pfucnego.
Material i metody: Do badania wtq-
czono 112 chorych leczonych operacyjnie
w latach 1996-1999. U 61 chorych (55%)
rozpoznano postac raka ptaskonabton-
kowego, u 30 (27%) gruczolakoraka,
u 10 (9%) raka wielokomorkowego i u 10
(9%) chorych postacie mieszane. Stopien
zaawansowania nowotworu ksztattowat siE2
nast~pujqCo: 1=54 (48%), 11=11 (10%),
111=40 (36%), IV=7 (6%). Materiat do ana-
Iizy molekularnej stanowifo DNA izolowane
ze swiezo mrozonych wycink6w guza
pobranych podczas zabiegu operacyjnego.
AGCN okreslano za pomocq podwojnie
roznicowej reakcji polimerazy i elektro-
forezyagarozowej.
Wyniki: Srednia wartosc AGCN dla erbS-
1 wynosHa 2,0 (zakres od 0,01 do 28,07),
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